₹ 256.00
-1.95 (-0.76%)
BSE
S
Samrat Pharmachem
₹ 256.00
BSE
Samrat Pharmachem EPS Summary
The latest quarterly EPS of Samrat Pharmachem as of Q1 Jun 2026 stands at ₹2.84. This is a 143.10% growth quarter on quarter and 483.78% growth same quarter last year. For the FY2026 the EPS of Samrat Pharmachem stands at ₹-10.72. This is a 146.57% fall compared with FY2025.
Samrat Pharmachem EPS
EPS by Peers

S
Sun Pharmaceutical

D
Divis Laboratories

T
Torrent Pharmaceuticals

L
Laurus Labs

Z
Zydus Life Science
*Based on consolidated figures.

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App

